These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 31529284)
21. Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection. Sharma G; Modgil A; Layek B; Arora K; Sun C; Law B; Singh J J Control Release; 2013 Apr; 167(1):1-10. PubMed ID: 23352910 [TBL] [Abstract][Full Text] [Related]
22. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk. Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998 [TBL] [Abstract][Full Text] [Related]
23. Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo. Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J Nanomedicine; 2020 Jan; 23():102112. PubMed ID: 31669083 [TBL] [Abstract][Full Text] [Related]
24. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357 [TBL] [Abstract][Full Text] [Related]
25. Brain-targeted delivery of losartan through functionalized liposomal nanoparticles for management of neurogenic hypertension. Lamptey RNL; Sun C; Singh J Int J Pharm; 2023 Apr; 637():122841. PubMed ID: 36925022 [TBL] [Abstract][Full Text] [Related]
26. Penetratin Peptide-Functionalized Gold Nanostars: Enhanced BBB Permeability and NIR Photothermal Treatment of Alzheimer's Disease Using Ultralow Irradiance. Yin T; Xie W; Sun J; Yang L; Liu J ACS Appl Mater Interfaces; 2016 Aug; 8(30):19291-302. PubMed ID: 27411476 [TBL] [Abstract][Full Text] [Related]
27. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models. Zhao L; Gottesdiener AJ; Parmar M; Li M; Kaminsky SM; Chiuchiolo MJ; Sondhi D; Sullivan PM; Holtzman DM; Crystal RG; Paul SM Neurobiol Aging; 2016 Aug; 44():159-172. PubMed ID: 27318144 [TBL] [Abstract][Full Text] [Related]
28. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma. Yuan M; Qiu Y; Zhang L; Gao H; He Q Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724 [TBL] [Abstract][Full Text] [Related]
29. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma. Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329 [TBL] [Abstract][Full Text] [Related]
30. Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer's disease therapy. Andrade S; Pereira MC; Loureiro JA Colloids Surf B Biointerfaces; 2023 May; 225():113270. PubMed ID: 36996633 [TBL] [Abstract][Full Text] [Related]
31. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773 [TBL] [Abstract][Full Text] [Related]
32. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease. Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771 [TBL] [Abstract][Full Text] [Related]
33. Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP/PS1 mice. Papadia K; Giannou AD; Markoutsa E; Bigot C; Vanhoute G; Mourtas S; Van der Linded A; Stathopoulos GT; Antimisiaris SG Eur J Pharm Sci; 2017 May; 102():180-187. PubMed ID: 28285172 [TBL] [Abstract][Full Text] [Related]
35. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier. Shi D; Mi G; Shen Y; Webster TJ Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016 [TBL] [Abstract][Full Text] [Related]
36. Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin. Li J; Zeng H; You Y; Wang R; Tan T; Wang W; Yin L; Zeng Z; Zeng Y; Xie T J Nanobiotechnology; 2021 Sep; 19(1):289. PubMed ID: 34565383 [TBL] [Abstract][Full Text] [Related]
37. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT. Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793 [TBL] [Abstract][Full Text] [Related]
39. Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice. Alata W; Ye Y; St-Amour I; Vandal M; Calon F J Cereb Blood Flow Metab; 2015 Jan; 35(1):86-94. PubMed ID: 25335802 [TBL] [Abstract][Full Text] [Related]
40. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy. Mojarad-Jabali S; Farshbaf M; Hemmati S; Sarfraz M; Motasadizadeh H; Shahbazi Mojarrad J; Atyabi F; Zakeri-Milani P; Valizadeh H Int J Pharm; 2022 Feb; 613():121395. PubMed ID: 34933080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]